The Drug-Drug Interactions Ontology

Last uploaded: February 11, 2016
Preferred Name

vismodegib

Synonyms

2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfonyl)benzamide

C19H14Cl2N2O3S

vismodegib

vismodegibum

Erivedge

2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-methanesulfonylbenzamide

ID

http://purl.obolibrary.org/obo/CHEBI_66903

AHFScode

10:00

ATCCode

L01XX43

blocks

http://purl.obolibrary.org/obo/dinto_3003

CASRN

879085-55-9

DBBrand

erivedge

DBSynonym

rg-3616

hedgehog antagonist gdc-0449

gdc-0449

Definition

A benzamide obtained by formal condensation between the carboxy group of 2-chloro-4-(methylsulfonyl)benzoic acid and the anilino group of 4-chloro-3-(pyridin-2-yl)aniline. Used for the treatment metastatic basal cell carcinoma.

Vismodegib inhibits the hedgehog signalling pathway and is indicated for treatment of adult basal cell carcinoma. FDA approved on Jan 30, 2012.

has pharmacological target

http://purl.obolibrary.org/obo/dinto_3003

has role

http://purl.obolibrary.org/obo/CHEBI_35610

http://purl.obolibrary.org/obo/CHEBI_66908

InChI

InChI=1S/C19H14Cl2N2O3S/c1-27(25,26)13-6-7-14(17(21)11-13)19(24)23-12-5-8-16(20)15(10-12)18-4-2-3-9-22-18/h2-11H,1H3,(H,23,24)

InChI=1/C19H14Cl2N2O3S/c1-27(25,26)13-6-7-14(17(21)11-13)19(24)23-12-5-8-16(20)15(10-12)18-4-2-3-9-22-18/h2-11H,1H3,(H,23,24)

InChIKey

InChIKey=BPQMGSKTAYIVFO-UHFFFAOYNA-N

InChIKey=BPQMGSKTAYIVFO-UHFFFAOYSA-N

inhibits

http://purl.obolibrary.org/obo/dinto_0883

http://purl.obolibrary.org/obo/dinto_2058

http://purl.obolibrary.org/obo/dinto_0291

http://purl.obolibrary.org/obo/dinto_1221

is metabolised by

http://purl.obolibrary.org/obo/dinto_2058

http://purl.obolibrary.org/obo/dinto_0901

is substrate of

http://purl.obolibrary.org/obo/dinto_3582

http://purl.obolibrary.org/obo/dinto_0217

is transported by

http://purl.obolibrary.org/obo/dinto_1440

label

vismodegib

may interact with

http://purl.obolibrary.org/obo/CHEBI_66901

http://purl.obolibrary.org/obo/CHEBI_2955

http://purl.obolibrary.org/obo/CHEBI_8776

http://purl.obolibrary.org/obo/CHEBI_3732

http://purl.obolibrary.org/obo/dinto_DB00199

http://purl.obolibrary.org/obo/CHEBI_7772

prefixIRI

obo2:CHEBI_66903

prefLabel

vismodegib

SMILES

CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1

CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(c2)-c2ccccn2)c(Cl)c1

Synonym

2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfonyl)benzamide

C19H14Cl2N2O3S

vismodegib

vismodegibum

Erivedge

2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-methanesulfonylbenzamide

xref

CiteXplore:22777303

CiteXplore:21753154

CiteXplore:22718857

CiteXplore:22844657

National Drug Code Directory:50242-140-01

Drugs.com:http://www.drugs.com/mtm/vismodegib.html

Reaxys:12532124

Wikipedia:http://en.wikipedia.org/wiki/Vismodegib

ChEMBL:560092

CiteXplore:22805146

CiteXplore:22679179

CiteXplore:22788238

RxList:http://www.rxlist.com/erivedge-drug.htm

Wikipedia:Vismodegib

PharmGKB:PA166048558

CiteXplore:22489352

CiteXplore:21610148

CASRN:879085-55-9

CiteXplore:22653209

ChEBI:66903

CiteXplore:22458643

CiteXplore:22670904

CiteXplore:22670903

CiteXplore:21602311

CiteXplore:22618984

subClassOf

http://purl.obolibrary.org/obo/dinto_000055

Delete Subject Author Type Created
No notes to display